MERKEL CELL CARCINOMA

Clinical trials for MERKEL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new MERKEL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 15 Not yet recruiting 1 Not yet finished but already full! 11 Completed 1 Terminated 6

New hope for Tough-to-Treat skin cancer after immunotherapy fails

Disease control Not yet recruiting

This study is testing a new combination of two drugs, ASTX727 (a pill) and retifanlimab (an IV infusion), for people with advanced Merkel cell carcinoma, a rare and aggressive skin cancer. It is specifically for patients whose cancer has continued to grow or spread despite receiv…

Matched conditions: MERKEL CELL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MERKEL CELL CARCINOMA

Get alerted when new MERKEL CELL CARCINOMA trials appear

New hope for Tough-to-Treat skin cancer after immunotherapy fails